Recommendation
The public was concerned about toilet paper scarcity, but medtech and biopharma companies had other shortages in mind. Would there be enough masks and gloves and other medical supplies to go around? What if manufacturers shut down or suppliers became inaccessible? The COVID-19 pandemic exposed fragility in the global supply chain, but medical supply vulnerabilities were among the scariest revelations of the pandemic. Biopharma and medtech companies can assess their supply chain resiliency using this report from the Boston Consulting Group.
Summary
About the Authors
Megan DeFauw, Shana Topp, Bryan Head, Ben Aylor and Aaron Snyder are professionals with the Boston Consulting Group.
By the same authors
Learners who read this summary also read
Related Skills
Aerospace and Defense Industry
Agriculture Industry
Food and Beverage Industry
Metals and Minerals Industry
Transport and Logistics
Entrepreneurship
Executive Leadership
Innovation
Lead Strategically
Manage Risk
Management
Market Insights by Industry
Plan Strategically
Sustainability
Understand Economics
Develop Innovative Products
Future of Pharma
Manage Crises
Manufacturing Industry
Understand Climate Risks
Manufacturing Challenges
Metals and Minerals Challenges
Pharmaceutical Industry
Manage Supply Chain Operations
Transport and Logistics Challenges
Manage Supply Chain Risks
Food and Beverage Challenges
Supply and Demand
Production and Logistics
Agricultur Challenges
Discover Supply Chain Risks
Manage Climate Risks
Aerospace and Defense Challenges
Ensure Business Continuity
Make Supply Chain Transparent
Pharma Challenges
Comment on this summary